노보큐어 리미티드
DE ˙ DB ˙ JE00BYSS4X48
€15.18 ↑1.51 (11.05%)
2026-06-05
주가
SecurityDE:038 / NovoCure Limited
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership17,874 shares
Latest Disclosed Value $ 194,808
Captrust Financial Advisors reports 67.89% increase in ownership of 038 / NovoCure Limited

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 17,874 shares of NovoCure Limited (DE:038) valued at $157,470 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 10,646 shares of NovoCure Limited. This represents a change in shares of 67.89% during the quarter. The current value of the position is $271,238 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 17,874 7,228 67.89 195 41.61 0.0003
2026-02-17 2025-12-31 13F NOVOCURE LTD ORD SHS Stock G6674U108 10,646 10,646 138 0.0003
2022-11-16 2022-09-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 0 -1,239 -100.00 0 -100.00
2022-08-23 2022-06-30 13F/A-1 NOVOCURE LTD ORD SHS Common Stock G6674U108 1,239 360 40.96 86 17.81 0.0006
2022-08-16 2022-06-30 13F NOVOCURE LTD ORD SHS COM G6674U108 1,292 413 90 0.0007
2022-05-16 2022-03-31 13F NOVOCURE ORD SHS G6674U108 879 126 16.73 73 28.07 0.0005
2022-02-14 2021-12-31 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 753 -10 -1.31 57 -35.96 0.0004
2021-11-16 2021-09-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 763 -442 -36.68 89 -66.67 0.0007
2021-08-16 2021-06-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 1,205 851 240.40 267 468.09 0.0025
2021-05-17 2021-03-31 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 354 269 316.47 47 213.33 0.0005
2021-02-16 2020-12-31 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 85 0 0.00 15 50.00 0.0002
2020-11-17 2020-09-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 85 -143 -62.72 10 -28.57 0.0002
2020-08-14 2020-06-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 228 228 14 0.0002
2020-02-14 2019-12-31 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 0 -516 -100.00 0 -100.00
2019-11-14 2019-09-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 516 150 40.98 39 69.57 0.0014
2019-08-13 2019-06-30 13F NOVOCURE LTD ORD SHS Common Stock G6674U108 366 366 23 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.